Antimicrobial resistance in Gram-positive pathogens isolated in the UK between October 1996 and January 1997

被引:26
作者
Andrews, J [1 ]
Ashby, J
Jevons, G
Lines, N
Wise, R
机构
[1] City Hosp NHS Trust, Dept Med Microbiol, Birmingham B18 7QH, W Midlands, England
[2] City Hosp NHS Trust, Pathol Comp Dept, Birmingham B18 7QH, W Midlands, England
关键词
D O I
10.1093/jac/43.5.689
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Antimicrobial resistance in Gram-positive pathogens from 30 centres in the UK (ten Teaching, ten Associate Teaching and ten District General Hospitals) was studied over a 4 month period between October 1996 and January 1997. High-level resistance (HLR) and low-level resistance (LLR) to penicillin amongst pneumococci was 3.3% and 3.4%, respectively. However, considerable variation in resistance rates was observed depending on geographical location (LLR range 0-15.4% and HLR range 0-30.8%). Considerable variation in resistance rates was also observed for Staphylococcus aureus to methicillin, with rates ranging from 0% to 56.7% depending on locality. Using conventional MIC methodology, none of the isolates of S. aureus was considered as having reduced sensitivity to vancomycin. However, eight isolates grew on Brain Heart Infusion Agar containing vancomycin (4 mg/L) after prolonged incubation and are therefore worthy of further investigation by electron microscopy. With Enterococcus faecalis, resistance rates were similar between the three types of hospital and only four isolates were considered resistant to glycopeptide antibiotics (one vanA and three vanB phenotype).
引用
收藏
页码:689 / 698
页数:10
相关论文
共 20 条
[1]   ANTIMICROBIAL RESISTANCE IN STREPTOCOCCUS-PNEUMONIAE - AN OVERVIEW [J].
APPELBAUM, PC .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) :77-83
[2]   Pneumococcal resistance to beta-lactam antibiotics: A global geographic overview [J].
Baquero, F .
MICROBIAL DRUG RESISTANCE, 1995, 1 (02) :115-120
[3]   In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristin [J].
Bouanchaud, DH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 :15-21
[4]  
Centers for Disease Control and Prevention (CDC), 1997, MMWR MORB MORTAL WKL, V46, P765
[5]  
*COM ANT SOC FRANC, 1996, CLIN MICROBIOLOGY S1, V2
[6]   AMANTADINE PROPHYLAXIS FOR HEALTH-CARE WORKERS - UNANSWERED QUESTIONS [J].
COX, RA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (01) :1-3
[7]   Antimicrobial susceptibility of community-acquired bacterial lower respiratory tract pathogens [J].
Felmingham, D ;
Robbins, MJ ;
Dencer, C ;
Nathwani, A ;
Gruneberg, RN .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (04) :747-751
[8]   HIGH-LEVEL MUPIROCIN RESISTANCE IN STAPHYLOCOCCUS-AUREUS - EVIDENCE FOR 2 DISTINCT ISOLEUCYL-TRANSFER RNA-SYNTHETASES [J].
GILBART, J ;
PERRY, CR ;
SLOCOMBE, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (01) :32-38
[9]   Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50 [J].
Hanaki, H ;
Kuwahara-Arai, K ;
Boyle-Vavra, S ;
Daum, RS ;
Labischinski, H ;
Hiramatsu, K .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (02) :199-209
[10]   Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility [J].
Hiramatsu, K ;
Hanaki, H ;
Ino, T ;
Yabuta, K ;
Oguri, T ;
Tenover, FC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) :135-136